Hiroshi Uchino

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Psychometric Properties

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, metabolic syndrome and obesity : targets and therapy

Journal of diabetes investigation

Diabetology international

This page only lists publications with an associated author ORCID identifier.

Publications

Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Manabu Saito, Hiroshi Uchino, Yoko Iwata, Ayako Fuchigami, Genki Sato, Fukumi Yoshikawa, Masahiko Miyagi, Taito Miyazaki, Yoshihisa Urita, Kotaro Aoki, Yoshikazu Ishii, Kazuhiro Tateda, Takahisa Hirose
Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Manabu Saito, Hiroshi Uchino, Yoko Iwata, Ayako Fuchigami, Genki Sato, Fukumi Yoshikawa, Masahiko Miyagi, Taito Miyazaki, Yoshihisa Urita, Kotaro Aoki, Yoshikazu Ishii, Kazuhiro Tateda, Takahisa Hirose
Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Yosuke Shimizu, Junko Tatebe, Toshisuke Morita, Takahisa Hirose
Quantitative evaluation of insulin-induced abdominal subcutaneous dystrophic tissue using shear wave elastography. Journal of diabetes investigation 13 (6) (2022)
Fukumi Yoshikawa, Hiroshi Uchino, Tomoko Nagashima, Shuki Usui, Masahiko Miyagi, Yasuyo Ando, Takahisa Hirose
Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial. Diabetology international 13 (1) (2021)
Kaori Hisanaga, Hiroshi Uchino, Naoko Kakisu, Masahiko Miyagi, Fukumi Yoshikawa, Genki Sato, Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Ken Kanazawa, Hiroshi Uchino, Fumika Shigiyama, Hiroyuki Igarashi, Kayoko Ikehara, Fukumi Yoshikawa, Shuki Usui, Masahiko Miyagi, Hiroshi Yoshino, Yasuyo Ando, Naoki Kumashiro, Takahisa Hirose
Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study. Journal of diabetes investigation 10 (4) (2019)
Masahiko Miyagi, Hiroshi Uchino, Naoki Kumashiro, Mariko Higa, Koki Shin, Makiko Sasamoto, Hiroji Kitazato, Motoyuki Tamaki, Munehide Matsuhisa, Takahisa Hirose
Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (5) (2018)
Ryo Iga, Hiroshi Uchino, Ken Kanazawa, Shuki Usui, Masahiko Miyagi, Naoki Kumashiro, Hiroshi Yoshino, Yasuyo Ando, Takahisa Hirose
Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial. Diabetes therapy : research, treatment and education of diabetes and related disorders 8 (4) (2017)